Magle Chemoswed Holding AB (STU:52X) 3-Year EBITDA Growth Rate : 14.10% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Magle Chemoswed Holding AB 3-Year EBITDA Growth Rate?

Magle Chemoswed Holding AB's EBITDA per Share for the three months ended in Sep. 2024 was €0.22.

During the past 12 months, Magle Chemoswed Holding AB's average EBITDA Per Share Growth Rate was 91.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 14.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 33.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Magle Chemoswed Holding AB was 48.60% per year. The lowest was 14.10% per year. And the median was 18.60% per year.

Competitive Comparison of Magle Chemoswed Holding AB's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Magle Chemoswed Holding AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Magle Chemoswed Holding AB's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Magle Chemoswed Holding AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Magle Chemoswed Holding AB's 3-Year EBITDA Growth Rate falls into.

Magle Chemoswed Holding AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Magle Chemoswed Holding AB (STU:52X) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Magle Chemoswed Holding AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Magle Chemoswed Holding AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Magle Chemoswed Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (STU:52X) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

MAGLE:Sweden

Address

Agneslundsvagen 27, Malmo, SWE, 21215

Website

https://www.maglechemoswed.com

Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.

Magle Chemoswed Holding AB Headlines

No Headlines